Literature DB >> 21566681

DSM-5 and the 'Psychosis Risk Syndrome': The DSM-5 proposal is better than DSM-IV.

Scott W Woods1, Jon P Carlson, Thomas H McGlashan.   

Abstract

The American Psychiatric Association is considering the inclusion of the psychosis risk syndrome as a new diagnosis for DSM-5. The main evidence supporting inclusion is: (1) the patients meet criteria for having a current illness, (2) the patients are at high risk for becoming more severely ill, (3) no DSM-IV diagnosis accurately captures their current symptoms or future risk, (4) the diagnosis is reliable and valid, at least in the research setting, and (5) codification in DSM-5 will promote treatment and prevention research of sufficient quantity and quality to permit the development of treatment guidelines. Field trials are needed to determine whether the proposed diagnostic criteria can be used with reliability in actual clinical practice.

Entities:  

Year:  2010        PMID: 21566681      PMCID: PMC3091012          DOI: 10.1080/17522439.2010.511719

Source DB:  PubMed          Journal:  Psychosis        ISSN: 1752-2439


  8 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study.

Authors:  Stephan Ruhrmann; Frauke Schultze-Lutter; Raimo K R Salokangas; Markus Heinimaa; Don Linszen; Peter Dingemans; Max Birchwood; Paul Patterson; Georg Juckel; Andreas Heinz; Anthony Morrison; Shôn Lewis; Heinrich Graf von Reventlow; Joachim Klosterkötter
Journal:  Arch Gen Psychiatry       Date:  2010-03

3.  Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Authors:  G Paul Amminger; Miriam R Schäfer; Konstantinos Papageorgiou; Claudia M Klier; Sue M Cotton; Susan M Harrigan; Andrew Mackinnon; Patrick D McGorry; Gregor E Berger
Journal:  Arch Gen Psychiatry       Date:  2010-02

4.  Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up.

Authors:  Alison R Yung; Barnaby Nelson; Carrie Stanford; Magenta B Simmons; Elizabeth M Cosgrave; Eoin Killackey; Lisa J Phillips; Andreas Bechdolf; Joe Buckby; Patrick D McGorry
Journal:  Schizophr Res       Date:  2008-09-02       Impact factor: 4.939

5.  Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study.

Authors:  Scott W Woods; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert Heinssen; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan
Journal:  Schizophr Bull       Date:  2009-04-21       Impact factor: 9.306

6.  Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America.

Authors:  Tyrone D Cannon; Kristin Cadenhead; Barbara Cornblatt; Scott W Woods; Jean Addington; Elaine Walker; Larry J Seidman; Diana Perkins; Ming Tsuang; Thomas McGlashan; Robert Heinssen
Journal:  Arch Gen Psychiatry       Date:  2008-01

7.  Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features.

Authors:  Alison R Yung; Lisa J Phillips; Hok Pan Yuen; Patrick D McGorry
Journal:  Schizophr Res       Date:  2004-04-01       Impact factor: 4.939

8.  Anticipating DSM-V: should psychosis risk become a diagnostic class?

Authors:  William T Carpenter
Journal:  Schizophr Bull       Date:  2009-07-24       Impact factor: 9.306

  8 in total
  3 in total

1.  Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort.

Authors:  G Brucato; M D Masucci; L Y Arndt; S Ben-David; T Colibazzi; C M Corcoran; A H Crumbley; F M Crump; K E Gill; D Kimhy; A Lister; S A Schobel; L H Yang; J A Lieberman; R R Girgis
Journal:  Psychol Med       Date:  2017-03-02       Impact factor: 7.723

2.  The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome.

Authors:  Scott W Woods; Barbara C Walsh; John R Saksa; Thomas H McGlashan
Journal:  Schizophr Res       Date:  2010-09-15       Impact factor: 4.939

3.  Treatment History of Youth At-Risk for Serious Mental Illness.

Authors:  Megan S Farris; Glenda MacQueen; Benjamin I Goldstein; JianLi Wang; Sidney H Kennedy; Signe Bray; Catherine Lebel; Jean Addington
Journal:  Can J Psychiatry       Date:  2018-08-02       Impact factor: 4.356

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.